Nikos Demiris

About Nikos Demiris

Nikos Demiris, With an exceptional h-index of 26 and a recent h-index of 18 (since 2020), a distinguished researcher at Athens University of Economics and Business, specializes in the field of Statistics, Epidemics, Biostatistics, Health Economics, Clinical Trials.

His recent articles reflect a diverse array of research interests and contributions to the field:

The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer

Abstract CT012: PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC)

A modelling framework for the analysis of the SARS-CoV2 transmission dynamics

NIMG-55. PREDICTING SITES OF TUMOR PROGRESSION IN THE INVASIVE MARGIN OF GLIOBLASTOMAS (PRAM-GBM STUDY): AN INTERIM ANALYSIS OF A MULTI-CENTER IMAGING BIOMARKER STUDY

Multiphasic stochastic epidemic models (preprint)

Periodic restriction of animal products rapidly decreases cardiovascular disease risk and reduces low-grade inflammation: the FastBio study

Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma

Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma

Nikos Demiris Information

University

Position

Assistant Professor

Citations(all)

1785

Citations(since 2020)

1031

Cited By

1025

hIndex(all)

26

hIndex(since 2020)

18

i10Index(all)

40

i10Index(since 2020)

29

Email

University Profile Page

Athens University of Economics and Business

Google Scholar

View Google Scholar Profile

Nikos Demiris Skills & Research Interests

Statistics

Epidemics

Biostatistics

Health Economics

Clinical Trials

Top articles of Nikos Demiris

Title

Journal

Author(s)

Publication Date

The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer

Nature

Jean E Abraham

Karen Pinilla

Alimu Dayimu

Louise Grybowicz

Nikolaos Demiris

...

2024/4/8

Abstract CT012: PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC)

Cancer Research

Jean E Abraham

Karen Pinilla

Louise Grybowicz

Alimu Dayimu

Nikolaos Demiris

...

2024/4/5

A modelling framework for the analysis of the SARS-CoV2 transmission dynamics

A Chatzilena

N Demiris

K Kalogeropoulos

2023/7/12

NIMG-55. PREDICTING SITES OF TUMOR PROGRESSION IN THE INVASIVE MARGIN OF GLIOBLASTOMAS (PRAM-GBM STUDY): AN INTERIM ANALYSIS OF A MULTI-CENTER IMAGING BIOMARKER STUDY

Neuro-Oncology

Stephen Price

Roxanne Mayrand

Yizhou Wan

Lynn Cream

Julia Cook

...

2023/11/1

Multiphasic stochastic epidemic models (preprint)

Petros Barmpounakis

Nikolaos Demiris

2023

Periodic restriction of animal products rapidly decreases cardiovascular disease risk and reduces low-grade inflammation: the FastBio study

medRxiv

Eleni M Loizidou

Alexandros Simistiras

Petros Barbounakis

Stavros Glentis

Alexandros Dimopoulos

...

2023/5/25

Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma

European Journal of Cancer

Ishan Mehta

Alimu Dayimu

Satish Kumar

Clare Boobier

Olabode Oladipo

...

2023/11/1

Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma

British Journal of Cancer

Alimu Dayimu

Lorena Di Lisio

Shubha Anand

Isart Roca-Carreras

Wendi Qian

...

2023/5/18

A Bayesian approach to the analysis of infectious disease data using continuous-time stochastic models

Νικόλαος Δεμίρης

Πέτρος Μπαρμπουνάκης

2023/9/19

Multiphasic stochastic epidemic models

arXiv preprint arXiv:2305.01043

Petros Barmpounakis

Nikolaos Demiris

2023/5/1

Bayesian Evidence Synthesis for Modeling SARS-CoV-2 Transmission

arXiv preprint arXiv:2309.03122

Anastasios Apsemidis

Nikolaos Demiris

2023/9/6

Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study

EClinicalMedicine

Anita Balakrishnan

Petros Barmpounakis

Nikolaos Demiris

Asif Jah

Harry VM Spiers

...

2023/5/1

SARS-COV2 TRANSMISSION DYNAMICS

Anastasia Chatzilena

Nikolaos Demiris

Konstantinos Kalogeropoulos

2023/7/12

Sample size determination via learning-type curves

arXiv preprint arXiv:2303.09575

Alimu Dayimu

Nikola Simidjievski

Nikolaos Demiris

Jean Abraham

2023/3/16

Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from Greece

Plos one

Petros Barmpounakis

Nikolaos Demiris

Ioannis Kontoyiannis

George N Pavlakis

Vana Sypsa

2022/4/21

TRANSMISSION OF SARS-COV2

Anastasia Chatzilena

Nikolaos Demiris

Konstantinos Kalogeropoulos

2022/3/9

Bayesian analysis of diffusion-driven multi-type epidemic models with application to COVID-19

arXiv preprint arXiv:2211.15229

Lampros Bouranis

Nikolaos Demiris

Konstantinos Kalogeropoulos

Ioannis Ntzoufras

2022/11/28

A modelling framework for the analysis of the transmission of SARS-CoV2

arXiv preprint arXiv:2203.03773

Anastasia Chatzilena

Nikolaos Demiris

Konstantinos Kalogeropoulos

2022/3/7

Inference and model determination for temperature-driven non-linear ecological models

arXiv preprint arXiv:2104.15043

Marios Kondakis

Nikolaos Demiris

Ioannis Ntzoufras

Nikos E Papanikolaou

2021/4/30

Abstract CT562: PARTNER: Randomised, phase II/III trial to evaluate the safety and efficacy of the addition of Olaparib to Platinum-based neoadjuvant chemotherapy in triple …

Cancer Research

Lynsey Drewett

Karen A Pinilla

Louise Grybowicz

Jerome Wulff

Alimu Dayimu

...

2022/6/15

See List of Professors in Nikos Demiris University(Athens University of Economics and Business)